News and Events
Check here for all news, announcements, events, and team updates for Papyrus Therapeutics.
Papyrus Therapeutics Inc. signs research collaboration with Oxford Biomedica
September 17, 2020 West Chester, Pennsylvania -: Papyrus Therapeutics, Inc. (“Papyrus” or the “Company”), an emerging biopharma company developing novel extracellular tumor suppressor therapies for the treatment of cancer and Oxford Biomedica plc...
Emerging roles for the GPI-anchored tumor suppressor OPCML in cancers – Anthony J, Zanini E, Bartley J R, Gabra H, Recchi C – Published June 29, 2020 in Cancer Gene Therapy
Papyrus Therapeutics Co-Founder Professor Hani Gabra recently contributed to this article about cancer gene therapy. Read the publication here: https://doi.org/10.1038/s41417-020-0187-6